Acadia Pharmaceuticals (ACAD): Q4 EPS of ($0.10) in line. Revenue of $588K beats by $38K. (PR)

|By:, SA News Editor
Acadia Pharmaceuticals (ACAD): Q4 EPS of ($0.10) in line. Revenue of $588K beats by $38K. (PR)